Furosemide and Strensiq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Furosemide (furosemide) and Strensiq (asfotase alfa). Common drug interactions include constipation among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Furosemide and Strensiq. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

What is Strensiq?

Strensiq has active ingredients of asfotase alfa. eHealthMe is studying from 7,141 Strensiq users. Check the latest studies of Strensiq.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

16 people who take Furosemide and Strensiq together, and have interactions are studied.

Furosemide and Strensiq drug interactions.

What are the common drug interactions of Furosemide and Strensiq, by gender? *:

female:

  1. Constipation
  2. Drug ineffective
  3. Asthma
  4. Device related infection
  5. Diarrhoea
  6. Iron deficiency anaemia
  7. Lung disorder (lung disease)
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Hypoxia (low oxygen in tissues)

male:

  1. Pneumonia
  2. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  3. Hypercalciuria (elevated calcium (ca+) level in the urine)
  4. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  5. Pseudomyxoma peritonei (uncommon tumour known for its production of mucus in the abdominal cavity)
  6. Acute respiratory failure
  7. Asthma
  8. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  9. Dermatitis diaper (diaper rash is a common form of inflamed skin)
  10. Influenza

What are the common drug interactions of Furosemide and Strensiq, by age (0-1 to 60+)? *:

0-1:

  1. Pneumonia
  2. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  3. Asthma
  4. Device related infection
  5. Diarrhoea
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Iron deficiency anaemia
  8. Lung disorder (lung disease)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Vomiting

2-9:

  1. Acute respiratory failure
  2. Asthma
  3. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  4. Dermatitis diaper (diaper rash is a common form of inflamed skin)
  5. Influenza
  6. Pneumonia
  7. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  8. Pneumonia viral

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Appendicitis noninfective (inflammation of the appendix-noninfective)
  2. Pseudomyxoma peritonei (uncommon tumour known for its production of mucus in the abdominal cavity)

What are the existing conditions these people have? *

  1. Hypophosphatasia (metabolic bone disease): 16 people, 100.00%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 4 people, 25.00%
  3. Urine Output - Decreased: 2 people, 12.50%
  4. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 12.50%
  5. Sedation: 2 people, 12.50%
  6. Pleural Effusion (water on the lungs): 2 people, 12.50%
  7. Hypotension (abnormally low blood pressure): 2 people, 12.50%
  8. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 2 people, 12.50%
  9. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 6.25%
  10. Lung Disorder (lung disease): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and Strensiq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Furosemide and Strensiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Strensiq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Furosemide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Strensiq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on furosemide and asfotase alfa (the active ingredients of Furosemide and Strensiq, respectively), and Furosemide and Strensiq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: